Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prostatic neoplasms

  • You have access
    Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer
    TAKASHI OGATA, RIHITO AIZAWA, KIYONAO NAKAMURA, TAKASHI KOBAYASHI, SHUSUKE AKAMATSU, EIJIRO NAKAMURA, OSAMU OGAWA and TAKASHI MIZOWAKI
    Anticancer Research August 2023, 43 (8) 3589-3596; DOI: https://doi.org/10.21873/anticanres.16538
  • You have access
    Serum γ-Glutamyltransferase as a Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide
    KOSUKE TAKEMURA, MASAYA ITO, YASUKAZU NAKANISHI, MADOKA KATAOKA, KAZUMASA SAKAMOTO, HIROAKI SUZUKI, KEN-ICHI TOBISU and FUMITAKA KOGA
    Anticancer Research October 2019, 39 (10) 5773-5780; DOI: https://doi.org/10.21873/anticanres.13780
  • You have access
    Long-term Follow-up Results of CT-guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer
    YUKIHIRO HAMA and TATSUMI KAJI
    Anticancer Research October 2018, 38 (10) 5959-5962; DOI: https://doi.org/10.21873/anticanres.12942
  • You have access
    Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer
    MANUELA A. HOFFMANN, KASRA TAYMOORIAN, CHRISTIAN RUF, ARND GERHARDS, KARLHEINZ LEYENDECKER, THOMAS STEIN, FRANK M. JAKOBS and MATHIAS SCHRECKENBERGER
    Anticancer Research December 2017, 37 (12) 6871-6877;
  • You have access
    Valproic Acid Alters Angiogenic and Trophic Gene Expression in Human Prostate Cancer Models
    RAJU CHELLURI, TIFFANY CAZA, MARK R. WOODFORD, JAY E. REEDER, GENNADY BRATSLAVSKY and TIMOTHY BYLER
    Anticancer Research October 2016, 36 (10) 5079-5086;
  • You have access
    Low Production of Reactive Oxygen Species and High DNA Repair: Mechanism of Radioresistance of Prostate Cancer Stem Cells
    YOUNG SEOK KIM, MUN JUNG KANG and YONG MEE CHO
    Anticancer Research October 2013, 33 (10) 4469-4474;
  • You have access
    Study of Genetic and Epigenetic Alterations in Urine Samples as Diagnostic Markers for Prostate Cancer
    EFTHYMIOS DIMITRIADIS, THEODOROS KALOGEROPOULOS, STAMATIA VELAETI, SOTIRIOS SOTIRIOU, EVANGELOS VASSILIOU, LOUKAS FASOULIS, VASILIOS KLAPSAS, MICHALIS SYNESIOU, AIKATERINI APOSTOLAKI, THEONI TRANGAS and NIKOLAOS PANDIS
    Anticancer Research January 2013, 33 (1) 191-197;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire